Viewing data from:

CEFACLOR

ANDA

CEFACLOR | A065146 | YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$1.18

per ea

Lowest NADAC/Unit

$0.9134

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
61442017230CEFACLOR 500 MG CAPSULE	$1.18	EA	Generic	—	2026-06-17
61442017130CEFACLOR 250 MG CAPSULE	$0.9134	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain1 active DMF12 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

ACS DOBFAR SPACEFACLOR MONOHYDRATE

DMF 137801998

LUPIN LTDInactiveCEFACLOR USP AS MAUFACTURED IN MANDIDEEP, INDIA

DMF 132171998

BRISTOL MYERS SQUIBB COInactiveCEFACLOR

DMF 132181998

MIWONInactiveCEFACLOR MONOHYDRATE USP, NON-STERILE BULK

DMF 132261998

ELI LILLY AND COInactiveCEFACLOR

DMF 135981998

ELI LILLY AND COInactiveCEFACLOR

DMF 136221998

DISTA PRODUCTS CO DIV ELI LILLY AND COInactiveCEFACLOR

DMF 136471998

RANBAXY LABORATORIES LTDInactiveCEFACLOR

DMF 137901998

YUHAN CORPInactiveCEFACLOR BULK

DMF 142111997

TEVA PHARMACEUTICALS USA INCInactiveCEFACLOR USP

DMF 146051999

BIOCHIMICA OPOS SPAInactiveCEFACLOR BULK NON STERILE AADA CONVERSION

DMF 147541998

AUROBINDO PHARMA LTDInactiveCEFACLOR USP

DMF 196432006

KYONGBO PHARMACEUTICAL CO LTDInactiveCEFACLOR NON-STERILE API

DMF 202882006

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 250MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jan 22, 2004

No patent or exclusivity listings for this strength.

#002 — EQ 500MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Jan 22, 2004